The direction of the effects also confirms the trends reported earlier in Figure 3, Figure 4, Figure 5 and Figure 6: amyloid is increased in both non-AD conditions (Stable_MCI and HC) versus MCI_AD, while the other two analytes (T-tau, P-tau) are decreased. The gene discussed is MAPT; the disease is Alzheimer disease.